Robert Fogel

8.2k total citations · 1 hit paper
110 papers, 5.4k citations indexed

About

Robert Fogel is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Robert Fogel has authored 110 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 66 papers in Physiology and 29 papers in Endocrine and Autonomic Systems. Recurrent topics in Robert Fogel's work include Chronic Obstructive Pulmonary Disease (COPD) Research (56 papers), Obstructive Sleep Apnea Research (34 papers) and Asthma and respiratory diseases (32 papers). Robert Fogel is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (56 papers), Obstructive Sleep Apnea Research (34 papers) and Asthma and respiratory diseases (32 papers). Robert Fogel collaborates with scholars based in United States, Switzerland and United Kingdom. Robert Fogel's co-authors include David P. White, Atul Malhotra, Jill Edwards, Giora Pillar, Karen Schory, Donald Banerji, Francesco Patalano, Jadwiga A. Wedzicha, Kenneth R. Chapman and Amy S. Jordan and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Robert Fogel

105 papers receiving 5.3k citations

Hit Papers

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone ... 2016 2026 2019 2022 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
    2016 547 citations Jadwiga A. Wedzicha, Donald Banerji et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Fogel United States 41 4.2k 2.8k 2.5k 874 310 110 5.4k
Robert L. Owens United States 41 3.8k 0.9× 2.2k 0.8× 2.9k 1.2× 1.2k 1.4× 284 0.9× 187 5.3k
Juan F. Masa Spain 36 4.4k 1.0× 3.5k 1.2× 2.9k 1.1× 667 0.8× 206 0.7× 103 6.0k
Santiago Carrizo Spain 19 6.2k 1.5× 3.8k 1.4× 4.3k 1.7× 830 0.9× 326 1.1× 31 7.4k
Babak Mokhlesi United States 46 5.1k 1.2× 2.9k 1.0× 3.6k 1.4× 1.2k 1.3× 289 0.9× 139 7.1k
Peter J. Wijkstra Netherlands 37 1.8k 0.4× 3.0k 1.1× 1.1k 0.4× 242 0.3× 321 1.0× 132 4.3k
Lee K. Brown United States 25 1.5k 0.3× 1.2k 0.4× 1.0k 0.4× 346 0.4× 108 0.3× 85 2.3k
Francesco Fanfulla Italy 30 1.1k 0.3× 1.8k 0.6× 702 0.3× 353 0.4× 108 0.3× 130 3.3k
M. Jeffery Mador United States 39 1.6k 0.4× 3.1k 1.1× 894 0.4× 262 0.3× 117 0.4× 94 4.5k
Sanja Jelić United States 28 1.8k 0.4× 1.3k 0.5× 1.2k 0.5× 361 0.4× 50 0.2× 69 3.6k
Stefan Andreas Germany 32 1.9k 0.4× 1.9k 0.7× 1.0k 0.4× 142 0.2× 194 0.6× 159 3.7k

Countries citing papers authored by Robert Fogel

Since Specialization
Citations

This map shows the geographic impact of Robert Fogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Fogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Fogel more than expected).

Fields of papers citing papers by Robert Fogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Fogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Fogel. The network helps show where Robert Fogel may publish in the future.

Co-authorship network of co-authors of Robert Fogel

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Fogel. A scholar is included among the top collaborators of Robert Fogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Fogel. Robert Fogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jackson, David J., Njira Lugogo, Mark Gurnell, et al.. (2025). Tezepelumab Reduces and Eliminates OCS Use in OCS-Dependent Patients With Severe Asthma: Primary Results from the Phase 3b WAYFINDER Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5231–A5231. 1 indexed citations
3.
Price, David, Benjamin Jones, Andreas Clemens, et al.. (2020). Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database. SHILAP Revista de lepidopterología.
4.
Li, Jing, Jing Yang, Lingfei Kong, et al.. (2020). Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians. Asian Pacific Journal of Allergy and Immunology. 40(3). 223–231. 8 indexed citations
5.
Price, David, Jaco Voorham, Guy Brusselle, et al.. (2019). Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. npj Primary Care Respiratory Medicine. 29(1). 38–38. 34 indexed citations
6.
Frent, Stefan, Kenneth R. Chapman, Michael Larbig, et al.. (2018). Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME. American Journal of Respiratory and Critical Care Medicine. 199(1). 43–51. 4 indexed citations
7.
Wedzicha, Jadwiga A., Anthony D’Urzo, Karen Mezzi, et al.. (2014). QVA149 showed significant improvements in lung function and health status and was well tolerated versus glycopyrronium and tiotropium in patients with severe COPD: The SPARK study. European Respiratory Journal. 44(Suppl 58). 1893–1893. 2 indexed citations
8.
D’Urzo, Anthony, et al.. (2014). QVA149 improves dyspnoea and lung function versus tiotropium in symptomatic patients using LABA/ICS preceding study enrolment: The BLAZE study. European Respiratory Journal. 44(Suppl 58). P2418–P2418. 1 indexed citations
9.
D’Urzo, Anthony, Donald A. Mahler, Petter Olsson, et al.. (2014). Once-daily QVA149 improves dyspnoea, lung function and reduces rescue medication use in symptomatic patients with COPD using LAMA as prior medication: The BLAZE study. European Respiratory Journal. 44(Suppl 58). P288–P288. 2 indexed citations
10.
Chapman, Kenneth R., Eric Bateman, Petter Olsson, et al.. (2014). Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study. European Respiratory Journal. 44(Suppl 58). P918–P918. 1 indexed citations
11.
Fogel, Robert, Kathleen Shields, Jared Christensen, et al.. (2013). A phase II, randomised, placebo controlled trial of 12 weeks treatment with an oral p38 inhibitor in patients with COPD on a background of ICS/LABA. European Respiratory Journal. 42(Suppl 57). 186–186. 4 indexed citations
12.
Lo, Yu‐Lun, Amy S. Jordan, Atul Malhotra, et al.. (2006). Genioglossal muscle response to CO2 stimulation during NREM sleep. IRIS. 4 indexed citations
13.
Heinzer, Raphaël, Michael Stanchina, Atul Malhotra, et al.. (2005). Lung Volume and Continuous Positive Airway Pressure Requirements in Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 172(1). 114–117. 147 indexed citations
14.
Wellman, Andrew, Amy S. Jordan, Atul Malhotra, et al.. (2004). Ventilatory Control and Airway Anatomy in Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 170(11). 1225–1232. 226 indexed citations
15.
Malhotra, Atul, Giora Pillar, Robert Fogel, et al.. (2002). Pharyngeal Pressure and Flow Effects on Genioglossus Activation in Normal Subjects. American Journal of Respiratory and Critical Care Medicine. 165(1). 71–77. 95 indexed citations
16.
Fogel, Robert, Atul Malhotra, Giora Pillar, et al.. (2001). Genioglossal Activation in Patients with Obstructive Sleep Apnea versus Control Subjects. American Journal of Respiratory and Critical Care Medicine. 164(11). 2025–2030. 138 indexed citations
17.
Malhotra, Atul, Giora Pillar, Robert Fogel, et al.. (2000). Genioglossal But Not Palatal Muscle Activity Relates Closely to Pharyngeal Pressure. American Journal of Respiratory and Critical Care Medicine. 162(3). 1058–1062. 107 indexed citations
18.
Pillar, Giora, Atul Malhotra, Robert Fogel, et al.. (2000). Airway Mechanics and Ventilation in Response to Resistive Loading during Sleep. American Journal of Respiratory and Critical Care Medicine. 162(5). 1627–1632. 137 indexed citations
19.
Malhotra, Atul, Robert Fogel, Jill Edwards, Steven A. Shea, & David P. White. (2000). Local Mechanisms Drive Genioglossus Activation in Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 161(5). 1746–1749. 86 indexed citations
20.
Fogel, Robert, Cynthia D. Smith, Michael Laposata, et al.. (1999). d -Dimers in the Diagnosis of Pulmonary Embolism. American Journal of Respiratory and Critical Care Medicine. 159(5). 1445–1449. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert L. Owens Breakdown of academic impact, for papers by Juan F. Masa Breakdown of academic impact, for papers by Santiago Carrizo Breakdown of academic impact, for papers by Babak Mokhlesi Breakdown of academic impact, for papers by Peter J. Wijkstra Breakdown of academic impact, for papers by Lee K. Brown Breakdown of academic impact, for papers by Francesco Fanfulla Breakdown of academic impact, for papers by M. Jeffery Mador Breakdown of academic impact, for papers by Sanja Jelić Breakdown of academic impact, for papers by Stefan Andreas
Rankless by CCL
2026